Select Page

Randal Streck

Program Chair, General Science

Contact info:
Phone: (203) 596-4662
Office: MacDermid 215B

Academic Background:

Columbia University
Postdoctoral Research Associate, Anatomy & Cell Biology

University of California, Berkeley
Postdoctoral Fellow, Molecular Cell Biology

University of California, Berkeley
Ph.D, Molecular Biology
Dissertation: “Hormonal regulation of Drosophila glue protein genes and characterization of the Drosophila transposable element hobo”

Harvard University
B.A. magna cum laude, Biochemistry

Teaching Background:

Randal Streck holds the position of Academic Program Manager for General Science, which includes Chemistry, Environmental Science, Forensic Science, Physics, and Scientific Writing. His previous position at Post University was Assistant Academic Program Manager for Biology. His course specialties include biology laboratory and lecture courses, as well as scientific writing. He taught molecular biology at the University of California, Berkeley, as well as science and English courses at Athens College, Greece. In addition, he has presented research posters and talks at numerous national and international scientific conferences.

Professional Background:

  • Senior Principal Scientist, Pfizer

  • Principal Investigator/Research Biologist, National Center for Toxicology Research/FDA

Professional Activities:

National Academy of Sciences


Pfizer Individual Achievement Award, Pfizer Team Achievement Award, Pfizer Animal Care and Welfare Board 3 R’s Award, 2 NCTR Awards, FDA Office of Women’s Health Award, Center for Alzheimer’s Disease Research in New York Award

Research/Academic Interests:

How do chemicals affect gene expression during embryo development?

Representative Publications:

Bowman CJ, Streck RD, Chapin RE. Maternal-placental insulin-like growth factor
(IGF) signaling and its importance to normal embryo-fetal development. Birth
Defects Res B Dev Reprod Toxicol. 2010;89(4):339.

Paquette JA, Kumpf SW, Streck RD, Thomson JJ, Chapin RE, Stedman DB.
Assessment of the Embryonic Stem Cell Test and application and use in the
pharmaceutical industry. Birth Defects Res B Dev Reprod Toxicol. 2008;83(2):104.

Chapin R, Stedman D, Paquette J, Streck R, Kumpf S, Deng S. Struggles for
equivalence: in vitro developmental toxicity model evolution in pharmaceuticals
in 2006. Toxicol In Vitro. 2007;21(8):1545.

Streck RD, Kumpf SW, Ozolins TR, Stedman DB. Rat embryos express transcripts for cyclooxygenase-1 and carbonic anhydrase-4, but not for cyclooxygenase-2, during organogenesis. Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):57-69. PubMed PMID: 12852484.